Description
An agonist of GPR119; inhibits hepatic lipid accumulation in wild-type, but not GPR119 knockout, mice fed a high-fat diet at 10 mg/kg; increases plasma levels of GLP-1 in mice at 10 mg/kg prior to and following glucose administration; increases glucokinase activity in an enzyme assay (EC50 = 45.11 µM)
Formal name: 5-ethyl-2-[4-[4-[[4-(1H-tetrazol-1-yl)phenoxy]methyl]-2-thiazolyl]-1-piperidinyl]-pyrimidine
Synonyms:
Molecular weight: 448.5
CAS: 1037792-44-1
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes